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Abstract
Background: To study segmental structural and functional aortic properties in Turner syndrome (TS) patients. Aortic
abnormalities contribute to increased morbidity and mortality of women with Turner syndrome. Cardiovascular
magnetic resonance (CMR) allows segmental study of aortic elastic properties.
Method: We performed Pulse Wave Velocity (PWV) and distensibility measurements using CMR of the thoracic
and abdominal aorta in 55 TS-patients, aged 13-59y, and in a control population (n = 38;12-58y). We investigated
the contribution of TS on aortic stiffness in our entire cohort, in bicuspid (BAV) versus tricuspid (TAV) aortic valve-
morphology subgroups, and in the younger and older subgroups.
Results: Differences in aortic properties were only seen at the most proximal aortic level. BAV Turner patients had
significantly higher PWV, compared to TAV Turner (p = 0.014), who in turn had significantly higher PWV compared
to controls (p = 0.010). BAV Turner patients had significantly larger ascending aortic (AA) luminal area and lower AA
distensibility compared to both controls (all p < 0.01) and TAV Turner patients. TAV Turner had similar AA luminal
areas and AA distensibility compared to Controls. Functional changes are present in younger and older Turner
subjects, whereas ascending aortic dilation is prominent in older Turner patients. Clinically relevant dilatation
(TAV and BAV) was associated with reduced distensibility.
Conclusion: Aortic stiffening and dilation in TS affects the proximal aorta, and is more pronounced, although not
exclusively, in BAV TS patients.
Functional abnormalities are present at an early age, suggesting an aortic wall disease inherent to the TS. Whether
this increased stiffness at young age can predict later dilatation needs to be studied longitudinally.
Background
Turner syndrome (TS), occurring in approximately one
in 2500 live born girls [1], is associated with left sided
congenital cardiovascular defects. A bicuspid aortic
valve (BAV) is found in up to one third of TS patients
[2]. Aortic arch abnormalities such as a dysmorphic
aorta or coarctation can be found in up to 50% of the
patients [3–5]. Turner patients have increased risk of
acquired aortic disease such as progressive dilation of
the ascending aorta and dissection [2, 4, 6–11]. These
aortic abnormalities contribute to the increased cardio-
vascular morbidity and mortality of women with Turner
syndrome [4, 6, 12, 13]. Aortic dissection is a well-
known fatal complication in TS patients and often
occurs at a much younger age than in the general
population. Detection of the patient at increased risk is
difficult. The presence of a BAV, coarctation of a dilated
aorta, as well as hypertension heralds higher risk, and
warrants closer follow up [14]. But regardless of the
presence of risk factors, follow up of aortic diameters
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has been inadequate at reliably predicting cardiovascu-
lar risk [15].
Besides excellent morphologic imaging, cardiovascular
magnetic resonance (CMR) also allows assessment of
segmental functional elastic properties of the aorta. Loss
of aortic elasticity of the proximal aorta increases the left
ventricle’s afterload and is related to increased cardiovas-
cular risk [16]. In the older population as well as in
several disease states, arterial stiffness has been shown
to increase with age and to contribute to the pathogen-
esis of systolic hypertension and cardiovascular disease
(end stage renal disease, hypertension, and coronary
artery disease) [17–22].
Although numerous invasive and non-invasive descrip-
tors of aortic elastic properties have been described, most
outcome data center on aortic pulse wave velocity (PWV)
[23] and distensibility [20, 22, 24, 25]. Previously we have
shown that age-associated loss of elasticity is more pro-
nounced in the thoracic aorta compared to the abdominal
aorta in healthy controls [26]. We now hypothesized
that Turner syndrome is associated with proximal aor-
tic stiffening, and investigated the influence of age on
this stiffness increase. To our knowledge, this study is
the first to investigate segmental aortic properties in
Turner patients by means of CMR.
Methods
Patient population
Fifty-five consecutive female Turner patients, aged be-
tween 13 and 59 years, referred for routine morphologic
CMR of the aorta, were prospectively included. Pregnant
or lactating women, patients with pacemakers or implant-
able cardioverter defibrillators (ICD’s), aneurysm clips,
cochlear implants, neural stimulators, epileptic seizures,
large tattoos, significant claustrophobia or morbid obesity
that would not enable the subject to fit in the scanner,
were excluded from the study. Patients who had had aor-
tic valve replacement or arch stenting/surgery were ex-
cluded. The control group consisted of 38 apparently
normal female subjects, aged between 12 and 58 year, re-
cruited for a previous study on aortic PWV [26]. MR stud-
ies in all patients and controls were performed at the
Ghent University Hospital, Belgium and reviewed by a
single radiologist with 10 years of experience in cardiovas-
cular CMR (DGHD). Body height and weight were mea-
sured prior to the MR examination. BMI and BSA, using
the formula of weight divided by body height squared (kg/
m2) and Mosteller [27] respectively, were calculated. We
consulted the treating physicians and reviewed the patient
medical records for documentation of estrogen replace-
ment therapy (ERT). The study protocol was reviewed
and approved by the Ghent University ethics committee.
All patients and controls gave a written informed consent.
MR scan protocol
All patients and controls were scanned on a 1.5 T
magnet (Siemens, Erlangen). The scan protocol con-
sisted of HASTE images of the thorax and abdomen
(TR: 800 ms TE: 28 ms, FA: 160° ST: 6 mm). On four
locations along the aorta, a retrospectively ECG-gated
gradient-echo sequence with velocity encoding perpen-
dicular to the aorta was applied to measure through-
plane flow velocity (TR: 73 ms, TE: 4 ms, FA: 30°, ST:
6 mm, velocity sensitivity VENC: 150 cm/s, recon-
structed phases: 40): ascending and descending aorta at
the level of the pulmonary trunk were imaged in one
series except in case of an extremely tortuous aorta,
where two separate image planes were used; another
series was placed at the level of the diaphragm, and a
most distal series just above the aortic bifurcation [16].
A balanced fast field echo cine series with equal pixel
matrix was acquired in exactly the same orientation
(TR: 26–30 ms, TE: 1.2–1.5 ms, FA: 65–80, ST: 6 mm,
number of images per cardiac interval: 40). During this
breath hold, blood pressure was measured with a non
invasive blood pressure monitor, using an adapted to
size blood pressure cuff around the left upper arm
(Tesla NIBP, Mammendorf, Germany). Baseline blood
pressure was the average of all measurements that were
performed during transverse scans.
In addition a standard keyhole high temporal, high
spatial resolution MRA sequence of the entire aorta
(Isovolumetric (1.3 mm) matrix 240x320 pixels, FOV:
420x320mm, TR: 2.6 ms, TE: 0.9 ms, symmetrically
shared 33% peripheral K-space data for 20% central data
(TWIST, time-resolved angiography with stochastic tra-
jectories) was performed in patients. Aortic arch morph-
ology was classified as normal arch (Romanesque, no
stenosis and no arteria subclavia lusoria) or elongated
transverse arch, tortuous arch, crenel shaped arch or
gothic arch [4].
Postprocessing
Postprocessing was performed off-line by a single radi-
ologist (DGHD). It consisted first of manually drawing a
centerline in the aortic lumen on a parasagittal angio-
graphic planar reformatted image (so called candy cane
view of the aorta). Along this centerline, the distance
(Δx) was measured between the positions where the
Phase Contrast images of the ascending aorta, the aorta
at diaphragmatic level, and just above the aortic bifur-
cation were made (Additional file 1: Figure S1). On these
phase contrast images the aortic lumen was segmented
in an automated fashion [28]. Using in-house developed
MATLAB code, the last 5 data points of each flow-time
curve were cut and pasted in front of the time series, in
order to translate the curve in time, ensuring that the
onset of each curve was positioned after the start of the
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revised time series (Additional file 2: Figure S2). The
graphs were subsequently processed in a custom-made
PWV analysis tool as described by Grotenhuis et al. [29]:
the onset of the systolic wave front was automatically
determined from the resulting flow graph by the inter-
section point of the constant horizontal diastolic flow
and the upslope of the systolic wave front, the latter of
which was modeled by linear regression along the
upslope from the flow values between 20% and 80% of
the total range (Additional file 3: Figure S3). PWV was
calculated as the ratio of distance Δx per time Δt,
where Δx is the length of an aortic segment (thoracic,
abdominal or entire aorta, see Additional file 1: Figure
S1) measured on the MR image data along the center-
line, and Δt is the time duration needed for the pulse
wave velocity to travel that length through the aorta.
Maximum and minimum transverse aortic luminal areas
were manually located and drawn on the cine series.
Distensibility was calculated as:
D ¼ Amax‐Aminð Þ= Amin  Pmax‐Pminð Þð Þ
where Amax and Amin are maximum and minimum
area, Pmax is peak systolic blood pressure and Pmin is
minimal (diastolic) blood pressure; it is expressed as 1/
1000*mmHg. These blood pressures were taken from left
arm sphygmomanometric measurement during the actual
distensibility scan.
Statistical analysis
Statistical exploration was performed in Wizard v1.8.9
(OSX El Capitan v10.11.4).
Statistical analysis was performed in SPSS for
Windows (version 22; SPSS, Chicago, Illinois, USA).
Normality of distribution was explored with histograms
and Q-Q plots. Baseline data are expressed as mean
(standard deviation; SD) and compared with an inde-
pendent T-test if normally distributed. PWV values were
expressed as median (interquartile range) and compared
using the Kruskal Wallis test. For the multivariate ana-
lyses General Linear Modeling was used adjusting for
age, height, weight, heart rate and systolic blood pres-
sure as covariates. The dependent variables in these
models were ln-transformed PWV, distensibility and area
values because of some skewness towards higher values.
The level of significance was set at p < 0.05.
Results
Population characteristics
Clinical characteristics and cardiac parameters of both
the control and Turner population are listed in Table 1.
The Turner population was significantly shorter, and had
a higher BMI compared to controls. Haemodynamically,
TS patients had a similar mean systolic blood pressure
compared to controls, but presented with a higher mean
heart rate and diastolic blood pressure. Mean left ven-
tricular volume including stroke volume was smaller in
TS patients, even after normalization for Body Surface
Area (BSA). There was no significant difference in mean
left ventricular ejection fraction, nor in left ventricular
mass normalized for body surface area. As expected, TS
patients, being smaller, had significantly shorter de-
scending thoracic aorta and abdominal aortic lengths. In
contrast, their aortic arch length was similar to the con-
trols’. While all controls had tricuspid aortic valves, 16
Turner patients had a bicuspid aortic valve (BAV).
Comparison of aortic measurements in Turner patients
and in controls
The multivariate determinants of aortic wall properties
were assessed in a Generalized Linear Model (GLM) in-
cluding the presence of Turner syndrome and adjusting
for possible confounders: age, height, weight, heart rate
and systolic blood pressure. Age was included as a
covariate to take into account the potential effect of the
non-significant age difference between Turners and
controls.
The effect of the presence or absence of Turner
syndrome is shown in Fig. 1 where estimated marginal
means were plotted for thoracic, abdominal and total
aortic PWV, area and distensibility in Turner patients
versus controls. As expected in all models, age was the
strongest determinant. Turner patients had significantly
Table 1 Population characteristics
Control Turner p value
(n = 38) (n = 55)
Age (y) 34 (14) 29 (11) 0.060
Length (cm) 166 (8) 154 (7) <0.001
Weight (kg) 61 (11) 57 (11) 0.159
BMI (kg/m2) 21.8 (3.1) 24.3 (4.3) 0.003
BSA (Mosteller) 1.67 (.17) 1.56 (0.17) 0.003
Systolic BP (mmHg) 118 (14) 121 (16) 0.259
Diastolic BP (mmHg) 70 (9) 81 (12) <0.001
Heart Rate (bpm) 69 (10) 79 (13) <0.001
Bicuspid aortic valve (%) 0% 16%
Aortic arch length (mm) 97 (13) 102 (20) 0.158
Descending aorta (mm) 108 (15) 100 (13) 0.008
Abdominal aorta (mm) 170 (21) 158 (20) 0.007
Thoracic aortic PWV (m/s) a 3.7 (1.7) 4.4 (1.7) 0.127
Abdominal aortic PWV (m/s) a 4.7 (2.5) 4.8 (1.6) 0.829
Overall aortic PWV (m/s) a 4.1 (1.6) 4.4 (1.2) 0.23
Values are Mean (standard deviation), comparison using unpaired t-test. All
variables normally distributed, except PWV values (a) which are expressed as
median (interquartile range), comparison using the Kruskal-Wallis test. Bold
indicates <0.05
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higher thoracic aortic PWV (TA-PWV) compared to con-
trols. Abdominal PWV was similar, the higher overall aor-
tic PWV in Turner subjects being driven by the higher
TA-PWV. No statistically significant differences in aortic
area and distensibility were seen between Turner patients
and controls.
Fig. 1 PWV in thoracic, abdominal and entire aorta, aortic area and distensibility of ascending and descending aorta as well as at the level of the
diaphragm and distal abdominal aorta. Comparison of controls (white) vs Turner Syndrome (shaded). Data (estimated marginal means and 95%
confidence interval) and p-values were derived from a multivariate GLM including age, height, weight, heart rate and blood pressure as confounders
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The impact of aortic valve morphology on aortic
parameters
We then analysed the impact of aortic valve morph-
ology. Table 2 shows the baseline characteristics of the
BAV Turner patients, Tricuspid Aortic Valve (TAV)
Turner patients, and controls. There were no significant
differences between baseline population characteristics
of TAV and BAV Turner patients.
To assess the effect of aortic valve on the aortic prop-
erties, we performed a GLM analysis comparing con-
trols, TAV Turner and BAV Turner, again adjusting for
age, height, weight, heart rate and systolic blood pres-
sure. The results are plotted in Fig. 2, showing the
multivariate adjusted estimated marginal means (and
95% confidence interval) of the studied aortic parame-
ters. Overall, differences in aortic properties were seen
at the most proximal aortic level: BAV Turner patients
had significantly higher PWV, compared to TAV
Turner (p = 0.014), who in turn had significantly higher
PWV compared to controls (p = 0.010). BAV Turner pa-
tients had significantly larger AA luminal area and
lower AA distensibility compared to both controls (all
p < 0.01) and TAV Turner patients. TAV Turner had
similar ascending aortic luminal areas and ascending
aortic distensibility compared to Controls.
No consistent differences were seen across groups
in more distal aortic characteristics. Exceptions were
marginal (but significant) differences in diaphragmatic
area (larger in BAV Turner patients), and differences
in overall aortic PWV (Turner higher than controls),
again driven by the differences in thoracic PWV, as
abdominal PWV values were similar.
Adding left ventricular stroke volume, which was
significantly smaller in Turners compared to controls, to
these models did not substantially change the results
(data not shown).
The impact of age on aortic parameters
We plotted F and p values of the used GLM model
within the Turner group and the control group separ-
ately in Additional file 4: Table S1. Age is the main
determinant of PWV, aortic luminal area and distensi-
bility at all levels in both groups, only surpassed
slightly by systolic blood pressure for descending and
distal abdominal distensibility in Turner patients (and
weight for distal abdominal aortic area in the control
group).
Using the same model separately in the TAV Control
group, in the TAV Turner patient group and in the BAV
Turner patient group (F and p values in Additional file 5:
Table S2), the independent association between aortic
properties and age remain largely unchanged in both TAV
groups. Strikingly, in BAV Turners almost all effects of
age, blood pressure, height and weight were lost.
To further study whether the impact of Turner Syn-
drome on aortic properties is different in younger versus
older subjects, we divided all three subgroups into two
halves, above and below their respective median age.
Age cut-offs were 27 years for TAV Turner subjects;
23.5 years for BAV Turner subjects; 32 years for Con-
trols. A similar GLM model adjusting for age, height,
weight, heart rate and systolic blood pressure was used
and the results of proximal aortic properties are shown
in Fig. 3. Overall, the functional changes (borderline
increase in thoracic PWV and significant loss of prox-
imal aortic distensibility) are present in both younger
and older Turner subjects, whereas structural remodel-
ing (enlargement of ascending aortic) clearly is only
prominent in older BAV Turners.
Finally, we plotted the ascending aortic area in relation
to the ascending aortic distensibility for young and old
groups of controls, TAV and BAV Turner patients (Fig. 4).
This graph illustrates the inverse correlation between
Table 2 Subgroup characteristics and comparison
TAV Control TAV Turner BAV Turner Control-TAV Turner Control-BAV Turner TAV- BAV Turner
(n = 38) (n = 39) (n = 16) p p p
Age (y) 34 (14) 30 (12) 25 (9) 0.241 0.008 0.128
Length (cm) 166 (8) 154 (8) 152 (6) 0.000 0.000 0.466
Weight (kg) 61 (11) 58 (12) 55 (8) 0.329 0.099 0.458
Heart Rate (bpm) 69 (10) 78 (14) 83 (8) 0.002 0.000 0.120
BMI (kg/m2) 21.8 (3.1) 24.4 (4.8) 23.9 (2.8) 0.006 0.032 0.589
BSA (mosteller) 1.67 (0.17) 1.6 (0.2) 1.5 (0.1) 0.016 0.007 0.454
Systolic BP (mmHg) 118 (14) 123 (16) 118 (14) 0.151 0.982 0.316
Diastolic BP (mmHg) 70 (9) 82 (14) 80 (9) 0.000 0.002 0.528
Aortic arch length (mm) 97 (13) 99 (15) 110 (27) 0.542 0.021 0.055
Descending aorta (mm) 108 (15) 102 (13) 96 (12) 0.050 0.009 0.159
Abdominal aorta (mm) 170 (21) 156 (21) 163 (16) 0.005 0.235 0.245
Descriptive parameters per subgroup, with p-value (t-test; bold indicates <0.05) for each comparison of two subgroups
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ascending aortic area (BSA-normalised) and its distensibil-
ity (incremented and ln-transformed), or, larger aortas are
stiffer in older controls and Turner patients (p < 0.001),
regardless of aortic morphology. There is no such correl-
ation in the younger subjects (either controls or Turner
patients).
Fig. 2 PWV in thoracic, abdominal and entire aorta, aortic area and distensibility of ascending and descending aorta as well as at the level of the
diaphragm and distal abdominal aorta. Comparison of TAV controls, TAV Turners and BAV Turners. Data (estimated marginal means and 95%
confidence interval) and p-values were derived from a multivariate GLM including age, height, weight, heart rate and blood pressure
as confounders
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Fig. 3 Thoracic PWV, ascending aortic area and distensibility. Comparison younger half (white) vs older half (shaded) in TAV control group, TAV
Turner group and BAV Turner group. Data (estimated marginal means and 95% confidence interval) and p-values were derived from a multivariate
GLM including age, height, weight, heart rate and blood pressure as confounders
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Additional results
We found ERT in at least 43 of 55 Turner patients
(78%). Four patients previously received ERT, but it was
stopped or temporarily interrupted in the year of the
MR scan. Retrospectively, we could not rule out that the
remaining 8 patients ever had been on ERT (5 Turner
patients probably not on ERT, and unknown in 3).
Aortic arch morphology was normal (Romanesque, no
stenosis, no lusoric subclavian artery) in all 38 control
subjects, compared to only 20 out of 55 Turner patients.
Thirty-five Turner patients had aortic arch abnormal-
ities: 21 elongated transverse arches, 5 tortuous arches, 4
crenel shaped arches, 2 gothic arches, 6 subjects had an
aortic arch stenosis (5/6 were moderate stenosis), and 8
subjects had an arteria subclavia lusoria. Adding aortic
arch abnormalities to the GLM models did not impact
the models for PWV, but for AA distensibility and for
AA area, the aortic arch abnormalities competed with
the diagnosis of Turner Syndrome and/or presence of a
bicuspid aortic valve (i.e. partial co-linearity, especially
with BAV presence).
Discussion
In this study, we evaluated PWV, luminal area and dis-
tensibility of both the thoracic and abdominal aortic
segments in 55 Turner patients compared to controls.
The main findings of our study are that (i) only the
proximal aorta is significantly stiffer (PWV) in Turner
patients compared to controls, independently of body
height, (ii) the ascending aorta is significantly less dis-
tensible and also more enlarged in Turner patients
with a bicuspid aortic valve compared to Turner pa-
tients with a tricuspid aortic valve, and (iii) the func-
tional proximal aortic changes were largely similar
when comparing younger and older TS patients, but
aortic dilatation (more pronounced in BAV Turner pa-
tients) seems acquired/progressive, although this inter-
pretation should be seen as purely hypothesis-generating
due to the cross-sectional nature of our data. Those sub-
jects with clinically relevant dilatation (>2,5 cm/m2) had a
markedly reduced distensiblity. The scatterplot between
AA area/BSA and distensibility shows a distinct (almost
bimodal) distribution with dilated and stiff AA clearly
clustering compared to non-dilated and less stiff AA.
Our data supports the previously reported dilation of
the proximal segment of the aorta in Turner syndrome
[28, 30–32]. Matura et al. found that 24% of TS patients
had dilatation of the ascending aorta defined as exceed-
ing the 95th percentile of BSA-adjusted aortic diameter
for age-matched control women, and they proposed that
this group required close cardiological surveillance.
Within this cohort of dilated ascending aorta in TS, they
identified a population of TS at highest risk for dissec-
tion with a cut-off of BSA-adjusted aortic diameter
>2.5 cm/m2 or an absolute diameter >3.5 cm [28].
Extrapolating from these cut-offs we calculated that a
BSA-adjusted aortic diameter >2.5 cm/m2 would equate
a BSA-adjusted area of >4,91 cm2/m2. This cut-off was
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Fig. 4 Scatterplots of ascending aortic area (BSA-normalised) and distensibility (incremented and ln-transformed) in young (a) and old (b) Controls
and in young (c) and old (d) Turner patients, illustrating an inverse relation in the older half of both populations, irrespective of aortic valve
morphology (triangle = tricuspid valve; square = bicuspid valve). The reference line at a normalised ascending aortic area of 491 mm2/m2
corresponds to the cut-off aortic diameter of 2.5 cm/m2
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exceeded in our cohort by 11.4% of TAV Turner pa-
tients, 26,7% of BAV Turner patients, and none of the
controls (Chi-square test; p = 0.008). It is noteworthy
that those Turner subjects with dilated ascending aortas
were characterized by a clearly lower ascending aortic
distensibility (see Fig. 4). In 2011, Mortensen reported
that the ascending aorta in TS is diseased and dilated,
and that the proximal aortic diameter growth rate was
0.1–0.4 mm/year; presence of a BAV was associated with
a significantly increased growth rate [30].
Whilst it has been reported –using various methodolo-
gies- that Turner patients have a stiffer aorta compared
to controls [33–35], this is the first study using CMR
PWV to assess the functional properties of the aorta at
various aortic levels. Indeed, we confirm the previous
findings that Turner subjects have stiffer arteries, but ex-
tend this by documenting a preferential involvement of
the proximal aorta, especially in patients with a bicuspid
aortic valve. In addition, BAV Turner patients had a
(borderline) non-significantly longer aortic arch com-
pared to TAV Turner patients. An elongated mid arch
segment or more serious deformations of the entire arch
[36] have been reported in these patients. It could be
that a more precise way of quantifying aortic arch length
and deformation allows for better differentiation of abnor-
mality, and the relative impact on PWV of both aortic
arch morphology and aortic wall stiffness in Turner
syndrome.
In the younger half of our study subjects we found a
significantly lower ascending aortic distensibility and
borderline non-significant higher PWV of the thoracic
aorta in BAV Turner patients, but no significant differ-
ence in ascending aortic transverse area. In the older half
of our study population, we found significantly increased
thoracic aortic PWV and ascending aortic area, as well
as significantly decreased ascending aortic distensibility.
However, correlation of ascending aortic area and dis-
tensibility shows that the presence of a bicuspid valve
cannot on its own predict dilatation of the ascending
aorta. As aortic wall stiffness seems increased at early
age, before dilatation is detectable, we put forward the
idea to study the possible prediction of proximal aortic
dilatation from early distensibility measurements in fur-
ther longitudinal studies.
The association of Turner syndrome with aortic wall
disease presenting from young age, as we found in our
data, is consistent with reports that increased risk of
acute aortic dissection is present from as early as the
second decade of life [1, 12, 13], and that dissection may
occur as early as the first decade of life [37]. Gravholt et
al. have estimated the incidence of dissection of 36 per
100,000 Turner’s syndrome years, compared with an in-
cidence of 6 per 100,000 in the general population [38].
Meszaros found an incidence of dissection of 2.9/
100,000 patient years in a population study of 100,000
patients during 27 years in the hospitals of three
adjacent small towns in western Hungary [39]. Turner
patients are at risk of aortic dissection at a significantly
younger age (31–35 years) [38, 40] than the normal
female population (68 years) [41]. An et al. have re-
ported recently that the aortic arch, measured by ultra-
sound, was not dilated but less elastic in 25 adolescent
Turner patients compared to controls [42].
Our data support the closer follow up of those TS pa-
tients with a bicuspid aortic valve [7].
Which TAV Turner patients should be followed up
equally frequently, all or only a subset with stiffer aorta
at young age remains to be studied.
Whether TAV Turner patients can be followed up
safely with less frequent re-examinations needs to be
further studied. Current guidelines recommmend ‘full
evaluation with thoracic CMR at an age when it can be
performed without sedation’ in young Turner patients
[43]. A practical approach could be to initially use ultra-
sound, and refer to CMR if the aorta cannot adequately
be measured, and perform CMR at the age of 10 years;
further follow up is currently guided by BSA normalized
aortic diameters and the presence of risk factors [44].
Study limitations
A limitation of our study is the small number of patients,
especially when groups were divided in subgroups: the
total number of bicuspid Turner patients was only 16. In
addition the effect of estrogen replacement therapy (ERT)
and previous growth hormone therapy was not studied.
We did review the patient files for history of ERT, but with
the vast majority of Turner patients on ERT, we were not
able to divide into ERT/No ERT groups of sufficient size.
However, the effect of ERT on aortic diameter was not sta-
tistically significant (p = 0.08) in a prospective 5 year fol-
low up study (n = 78) [15]. In a smaller study the same
group has investigated the effect of 6 months of ERT on
ambulatory arterial stiffness index (AASI) derived from
24-hour ambulatory blood pressure: although Turner pa-
tients were found to have higher AASI when compared to
controls, AASI was unchanged by ERT [45].
The age difference between control population and
the 5 years younger Turner population was not signifi-
cant, but once subdivided in valve morphology groups,
the small BAV Turner patients were significantly youn-
ger than the TAV Turner patients. The older/younger
subdivision of our control and Turner patients at the
respective median line was chosen to preserve equal
number of subjects in both young and old groups. Sub-
division at one fixed age for all groups would hinder
proper statistical analysis, as this would lead to compar-
ing a large group of young Turner patients, with a small
group of young controls.
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Blood pressure measurement was performed during
the actual distensibility scan, but we were limited to a
left arm sphygmomanometric measurement. This may
not be representative for the blood pressure in the as-
cending aorta proximal to a dysmorphic arch.
The postprocessing of PWV is another limitation.
Detection of the foot of the curve is difficult in such a
fast physiologic process, when performed with the rela-
tively poor temporal resolution of MR. However this
limitation applies equally to all studied groups in this
study. Our data did not allow analyzing smaller aortic
segments. Other studies have focused on increasing tem-
poral resolution by acquiring in-plane velocity encoded
images [46, 47]. At the time our data acquisition started,
transverse images and detection of the foot-of-the-curve
time shift was the major proposed method, a transit-
time method focussing at the early systolic part of the
curve in an attempt to avoid the effect of wave reflec-
tion, which, especially in a stiffer aorta, is important. It
was used as early as 1993 by Mohiaddin et al. [48] and
more recently, by means of computer phantoms,
Dorniak et al. calculated the minimal required temporal
resolution of 30 ms (35 image frames at a heartrate of
60 bpm) for accurate and precise quantitative flow data
for CMR-PWV over the range 2–20 m/s in the thoracic
aorta [49]. Newer methods involve complex wavelet
cross spectrum analysis [50], which equally have the ad-
vantage of being robust at lower temporal resolution.
Our transverse aortic area measurements were not
corrected for longitudinal strain, which in the ascending
aorta reduces systolic dilation and thus leads to under-
estimation of distensibility [51]. However, ascending and
descending aortic distensibilities in our study are com-
parable. To minimize through-plane motion error, the
ascending aortic cine image was positioned carefully out
of range of the motion of the sinotubular junction. The re-
ported perpendicular aortic areas in our work are end-
diastolic. As for comparison with other PWV values in lit-
erature, it is important to note that the most critical aspect
of PWV postprocessing is the lack of standardization and
all-in-one software solutions.
Our data is not longitudinal. We can therefore not make
assumptions regarding the evolution of a stiffer proximal
aorta at young age towards dilatation at older age. We do
however think this should be studied further.
Conclusion
In conclusion, Turner patients exhibit a predominantly
proximal aortic stiffening and dilatation, especially -but
not exclusively- if their aortic valve is bicuspid. Aortic
stiffening in Turner syndrome is already present at an
early age, whereas ascending aortic dilatation is not. We
put forward the hypothesis that proximal aortic stiffness
at early age may predict aortic dilatation in both bicuspid
and tricuspid aortic valve Turner patients. This hypothesis
should be studied longitudinally.
Novelty and significance
What is new?
We have studied segmental thoracic versus abdominal
aortic Pulse Wave Velocity acquired with CMR in Turner
patients.
What is relevant?
In Turner patients, structural (dilatation) and functional
aortic wall changes (stiffening and loss of distensibility)
are restricted to the proximal aorta, even more so –but
not exclusively- in the presence of a bicuspid aortic valve.
Increased thoracic aortic wall stiffness is already present
at a young age whereas the aortic dilatation was only seen
in our older Turner patients, specifically in those with the
most pronounced stiffening.
If proximal aortic stiffness measurements could be
used to predict dilatation -and by extension, risk of
dissection- at older age, the follow-up criteria and timing
of both bicuspid and tricuspid aortic valve Turner pa-
tients could be redefined.
Summary
Turner patients exhibit a predominantly proximal aortic
stiffening and dilatation, especially -but not exclusively- if
their aortic valve is bicuspid. Aortic stiffening in Turner
syndrome is already present at an early age, whereas
ascending aortic dilatation is not. We put forward the
hypothesis that proximal aortic stiffness at early age may
predict aortic dilatation in both bicuspid and tricuspid
aortic valve Turner patients. This hypothesis should be
studied longitudinally.
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